Latest news
HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer - OncodailyOncodaily · Sat, 08 Aug 2026 11:14:59 GMTRemote Monitoring and Self-Efficacy: Implications for Breast Cancer Survivorship Outcomes - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Thu, 06 Aug 2026 22:42:59 GMTIceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment - PR NewswirePR Newswire · Thu, 06 Aug 2026 12:05:00 GMTWearable electric-field device slows aggressive breast cancer in preclinical study - EurekAlert!EurekAlert! · Wed, 05 Aug 2026 19:50:47 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMTThese Foods May Lower Breast Cancer Risk by 15%, New Study Suggests - EatingWellEatingWell · Mon, 03 Aug 2026 02:24:47 GMTHER2-Low and HER2-Ultralow: What the Categories Change in Practice - OncodailyOncodaily · Thu, 30 Jul 2026 07:00:00 GMT